SCHEMBL4698529

SCHEMBL4698529

N#CCc1cccc(-n2nnc(-c3ccccn3)n2)c1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 18/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4701833 0.84 GRM5 (0.71) GRM5
SCHEMBL4699614 0.84 GRM5 (0.70) GRM5
SCHEMBL4699469 0.82 GRM5 (0.69) GRM5
SCHEMBL6670750 0.82 GRM5 (0.67) GRM5
SCHEMBL6671850 0.82 GRM5 (0.67) GRM5
SCHEMBL660355 0.81 GRM5 (1.00) GRM5
SCHEMBL13068874 0.81 GRM5 (0.87) GRM5
SCHEMBL13683913 0.81 GRM5 (0.75) GRM5
SCHEMBL4703590 0.80 GRM5 (0.68) GRM5
SCHEMBL13683872 0.80 GRM5 (0.86) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434773-B1 HETEROARYL SUBSTITUTED TETRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2008-05-21 EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO claimed